NDONOVO THERAPEUTICS INC (ENDV) Revenue by Year

ENDV

NDONOVO THERAPEUTICS INC generated $135K in revenue in fiscal year 2022. This represents an increase of 85.2% from the prior fiscal year. Over the trailing 12 months, Q4 FY2022 through Q3 FY2023, the same line adds up to $256K in revenue. The table below carries 13 fiscal years, from 2010 to 2022, and the quarters NDONOVO THERAPEUTICS INC has filed alongside them.

FY2022 annual

Revenue $135K

YoY +85.2%

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2023, ended Sep 30, 2023 Reported Dec 29, 2023 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ENDV Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	TTM	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Revenue	$256K	$135K+85.2%	$73K-55.9%	$166K-46.5%	$310K+272.5%	$83K	N/A	N/A	$4K-82.4%	$24K+5.7%	$23K-25.1%	$31K-32.9%	$46K-11.0%	$51K

TTM is the trailing twelve months, Q4 FY2022 through Q3 FY2023, summed from the four most recent quarterly filings.

ENDV Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-Q	Q3'2210-Q	Q2'2210-Q	Q1'2210-Q	Q4'2110-K	Q3'2110-Q	Q2'2110-Q	Q1'2110-Q	Q4'2010-K
Revenue	$2K-86.1%	$45K+6853.8%	$88K+3736.1%	$121K+38337.7%	$11K+40.7%	$650-97.9%	$2K-93.4%	$316-97.3%	$8K-80.5%	$30K-32.1%	$35K-50.2%	$12K-92.3%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More NDONOVO THERAPEUTICS INC financials

Frequently Asked Questions

What was NDONOVO THERAPEUTICS INC's revenue in fiscal year 2022?

NDONOVO THERAPEUTICS INC generated $135K in revenue in fiscal year 2022.

How fast is NDONOVO THERAPEUTICS INC's revenue growing?

NDONOVO THERAPEUTICS INC (ENDV) revenue rose by 85.2% year over year, from $73K to $135K in fiscal year 2022.

What is NDONOVO THERAPEUTICS INC's revenue over the last twelve months?

NDONOVO THERAPEUTICS INC (ENDV) reported $256K in revenue over the trailing 12 months, Q4 FY2022 through Q3 FY2023, summed from the four most recent quarterly filings.

How has NDONOVO THERAPEUTICS INC's revenue changed over the years?

Across the 13 fiscal years this page covers, NDONOVO THERAPEUTICS INC (ENDV) revenue went from $51K in fiscal year 2010 to $135K in fiscal year 2022.

What was NDONOVO THERAPEUTICS INC's revenue in the most recent quarter?

NDONOVO THERAPEUTICS INC (ENDV) reported $2K in revenue in Q3 2023. This represents a decrease of 86.1% from the same quarter a year earlier.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what NDONOVO THERAPEUTICS INC (ENDV) reported on that line in every period on record.